Business Wire

Veeva Announces Vault Site Connect to Automate Information Sharing in Clinical Trials

Share

2020 Veeva R&D Summit, Europe — Veeva Systems (NYSE: VEEV) today announced Veeva Vault Site Connect, a new application that connects sponsors and clinical research sites during trials. Vault Site Connect automates the flow of information between Vault Clinical applications used by sponsors and Veeva SiteVault, a compliant eISF application used by sites for source document management and remote monitoring. Now sponsors and sites can streamline information sharing for key trial processes, including feasibility, study document exchange, safety letter distribution, and subject status for faster study execution.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200519005216/en/

Veeva Vault Site Connect automates the flow of information between clinical research sites and sponsors to speed trials.

Veeva Vault Site Connect automates the flow of information between clinical research sites and sponsors to speed trials.

“There is a significant opportunity to speed information exchange throughout the clinical trial process,” said Doug Schantz, member of SCRS leadership council and former head of U.S. site management and monitoring at AstraZeneca. “Veeva Vault Site Connect will transform how sponsors and sites work together and help get studies up and running much faster.”

Vault Site Connect seamlessly automates information flow across trial partners, processes, and systems. Sponsors can easily collect input from sites on study feasibility to spend less time coordinating surveys; accelerate document exchange and reconciliation between eTMF and eISF; quickly distribute safety letters to notify global sites and regulators of an adverse event; and get real-time information on the status of patients from enrollment through treatment – all with one application.

With Vault Site Connect, sponsors can improve site engagement by reducing the time and effort in exchanging clinical information. Now sites can focus less on administrative tasks and responding to information requests and more on execution and treating patients, improving overall study quality.

“Veeva Vault Site Connect will eliminate the many portal interfaces, manual handoffs, and multiple steps it takes to share data with sponsors during a trial,” said Tonya Yarbrough, director, Vanderbilt Institute for Clinical and Translational Research at Vanderbilt University Medical Center. “Now the industry can leverage the same innovative Veeva Vault technology to drive greater efficiency and productivity during trials.”

Vault Site Connect is part of the Veeva Clinical Network, a set of solutions that brings together sponsors, sites, and patients to accelerate clinical research. In addition to Vault Site Connect, Veeva today announced MyVeeva, a multichannel patient portal for virtual visits and patient-centric trials. Together with Veeva Vault Clinical Suite, Veeva is the first and only company providing solutions that help sponsors, sites, and patients share and view information during a clinical trial.

“Veeva aims to improve efficiency and collaboration across the clinical trial ecosystem,” said Rik Van Mol, vice president of strategy for Veeva Development Cloud. “With applications for sponsors, sites, and patients all part of the Veeva Clinical Network, we are providing a common way to connect and get real-time information throughout the course of a study.”

Vault Site Connect is planned for availability in August 2020. To learn how Site Connect automates information sharing in clinical trials, register for an upcoming webinar on 23 June at veeva.com/SiteConnectWebinar, as well as the online Veeva R&D Summit, 19-20 and 26 May, 2020.

Additional Information

For more on Veeva Vault Site Connect, visit: veeva.com/SiteConnectEU
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veeva_eu on Twitter: twitter.com/veeva_eu
Like Veeva on Facebook: facebook.com/veevasystems

About Veeva Systems

Veeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 850 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com/eu.

Forward-looking Statements

This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-K for the period ended January 31, 2020. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.

Contact information

Roger Villareal
Veeva Systems
925-264-8885
roger.villareal@veeva.com

Kiran May
Veeva Systems
+44-796-643-2912
kiran.may@veeva.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Altium Launches Initiatives to Help Electronics Industry Get “Back to Work”4.6.2020 10:00:00 EESTPress release

From home offices to virtual workplaces, the working environment has changed. For the Printed Circuit Board (PCB) design industry, Altium has helped make the transition seamless, empowering collaboration across every aspect of the design process. With Altium 365, the world’s only cloud-based platform for PCB design and realization, many of Altium’s customers were able to stay in motion even during the most challenging times. As the world gets back to business, Altium is making it easy for PCB designers to continue to work from anywhere and connect with anyone. “The workplace is more distributed than ever before, and at the same time our customers are dealing with unprecedented financial challenges,” says Ted Pawela, Altium’s COO. “We want to help the industry get back on track by making it easier than ever before to get the tools they need for PCB design, and work collaboratively in distributed work environments.” Coming Together Without Impacting Workflow Altium’s newest cloud-based p

WORTH Partnership Project: Organic Chairs, Fish Leather and Interactive Clothing4.6.2020 10:00:00 EESTPress release

Organic chairs that are “nourished” to reach desired shape, glassware derived from special waste, new alternative materials derived from fish to replace animal leather, illustrated children’s clothing that are enriched with new content through augmented reality and app interactions: Recycling, sustainability and the advanced use of technology attested that the mantra is always at the heart of creativity and innovative experiences by new generation European designers. All designers, under the Worth Partnership Project, an initiative financed by the European Union COSME programme, will be online from the 15th to 21st of June to showcase their projects and their concepts behind. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200604005050/en/ Worth Partnership Project_"Lucid", organic chair "nourished” to reach desired shape (Photo: WORTH Partnership Project) 7 video conferences for 7 topics in 7 days: to discover the Worth Part

ADVA launches industry’s first ePRC optical cesium clock solution4.6.2020 10:00:00 EESTPress release

ADVA (FSE: ADV) today launched the industry’s first ePRC optical cesium atomic clock solution, protecting synchronization networks from costly and dangerous interruptions to satellite signals. The Oscilloquartz OSA 3350 ePRC+ provides unprecedented stability and significantly longer lifetime compared to all other ePRC cesium clocks. It’s also the first cesium clock on the market with built-in SNMP support. This innovation in the design of atomic clocks comes at a critical time when GNSS outages caused by jamming and spoofing attacks are on the rise. Long GNSS disruptions can cause severe network outages and so the OSA 3350 ePRC+ offers vital backup for mission-critical infrastructures that depend on satellite-based timing, such as mobile networks and power utilities. The OSA 3350 ePRC+ also meets the stringent performance demands as well as the cost points needed for mobile networks transitioning to 5G. This press release features multimedia. View the full release here: https://www.bus

TMD Security Launches Global Consultancy Program with Deloitte to help ATM Deployers Discover Operational Cost Savings and Benefits From Key-less ATM & Branch Access Management4.6.2020 09:00:00 EESTPress release

TMD Security announced today the launch of a global program with consulting firm Deloitte to help banks and ATM deployers understand the annual operational cost savings and benefits from replacing physical keys and manual processes with a key-less ATM and Branch Access Management solution. Ten Deloitte customer engagements are planned in EMEA, APAC and the Americas and there is availability for a further ten free custom business case engagements before the end of the year. “Reducing ATM operational costs has never been more critical than it is today,’’ said Cees Heuker of Hoek, CEO and Founder, TMD Security. “We are proud to announce this global relationship with Deloitte. A custom business case gives valuable insight into an ATM deployer’s specific cost savings and business benefits potential, depending on their ATM network and current access processes. Our clients discover that replacing keys and manual processes with our Access Management solution results in staggering productivity

Bureau Veritas signs a global framework agreement with Shell to help contribute to the company’s ambition to reduce emissions from operations4.6.2020 08:45:00 EESTPress release

Reducing greenhouse gas emissions represents a major ambition of all energy operators. Bureau Veritas supports clients to meet society’s energy needs while building a more sustainable low carbon future. Methane emissions are a major component of indirect greenhouse gas emissions generated along the oil and gas value chain1. Shell, a leading global energy and petrochemicals group, has set a target to maintain methane emissions intensity below 0.2% by 20252. Bureau Veritas has been awarded a framework agreement to provide support and help enable the company to move towards achieving that target. With worldwide reach, the new enterprise framework agreement with Bureau Veritas allows Shell to benefit from expert solutions in detection of leaks across all assets. Bureau Veritas’ Leak Detection and Repair solutions (LDAR) enable Shell to monitor, quantify and control emissions in order to minimize its carbon footprint. These solutions integrate advanced technologies such as Optical Gas Imagi

Ferring and Igenomix Collaborate to Advance Care in Reproductive Medicine and Maternal Health4.6.2020 08:00:00 EESTPress release

Ferring Pharmaceuticals and Igenomix today announced a two-year research collaboration aimed at the discovery of novel targets and disease mechanisms in infertility and pregnancy-related conditions, including preeclampsia, with the goal of developing innovative diagnostic and therapeutic strategies in these areas of high unmet need. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200603005784/en/ A new research hub will be created in Boston, bringing together scientists and expertise from both companies. The hub will focus on investigating molecular signatures, developing novel functional genomic systems and creating translational tools to study for embryo implantation, endometrial microbiome interaction and decidualization biology to drive innovative solutions for patients. “Today, 1 in 6 couples worldwide are affected by fertility issues, with embryo implantation being a critical step to improving success rates in assisted

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom